IP issues relating to Generative AI AU perspectives & beyond

Hosted Webinar on IP issues relating to Generative AI – Australia’s perspective and beyond. With the adaption of Artificial Intelligence across many industries, companies will have to address novel issues relating to Intellectual Property Rights in this space.  This event will discuss the regulatory developments in AI, the legal risks of using AI (including IP risks), and how companies could best prepare for using AI in this area.

This event is proudly supported by:   

Alex Horder, Senior Associate, Australian AI lead | Technology, AI, Outsourcing, Commercial
Alex is a technology and outsourcing Lawyer, specialising in technology transactions and digital transformations, data security and privacy and technology disputes, with a sub-focus on Artificial Intelligence (AI) and HealthTech. Alex is also the Australian Lead for the DLA Piper Artificial Intelligence offering. Alex works closely with a range of clients in respect of business-critical technology and commercial matters, including, outsourcing and digital transformation, commercial contracting, strategic sourcing and procurement, AI, intellectual property commercialisation and technology disputes, and has considerable experience in negotiating against a range of major technology and telecommunications providers.

Tudor Filaret, Solicitor, Intellectual Property & Technology | Life Sciences

Tudor is an intellectual property and life sciences Lawyer, specialising in advising on litigious and non-contentious aspects of intellectual property law and therapeutic goods in Australia, with a sub-focus on AI and HealthTech. Tudor works closely with a range of clients in contentious intellectual property proceedings in the Federal Court of Australia and on intellectual property rights enforcement campaigns, and is well-informed about the evolving legal landscape concerning AI and its associated IP and consumer issues. Tudor also advises on the regulatory aspects of life sciences and HealthTech, including on software as a medical device, classification of medical devices, and on advertising and marketing.

The speakers will address the following topics:

  1. What is AI and Generative AI

  2. Regulatory update (good to give some currency)

  3. Risks of using AI

  4. Deep dive into AI and IP issues from an Australian and global perspective, including:

    • Copyright – inputs (infringing copyright)

    • Copyright – outputs (who owns the copyright)

    • Copyright – outputs (infringing copyright)

    • Patent issues

  5. IP Australia’s regulatory position

  6.  Practical business advice on how to address the above issues, including:

    • Managing your internal and external IP risks; and

    •  Commercial contracting perspectives

  7. Question time.


AI and machine learning technologies are transforming the way we do business.  From chatbots and natural language processing to classifiers and intelligent robotics, AI helps you automate and optimize processes.  Navigating regulatory compliance, liability risk, privacy, transparency, and ethics calls for a knowledgeable, experienced global team.  DLA Piper’s team is at the forefront of AI regulations and work closely with government agencies and industry associations to shape emerging rules.

10/19/2023 12:00 PM - 1:00 PM
AUS Eastern Daylight Time
Webinar via Zoom hosted by LESANZ Zoom links will be provided to all attendees
Online registration not available.